Pharma and healthcare services
Expert analytical testing and consulting to support all stages of drug development
LGC provides contract analytical research and testing services, consultancy and research programme management, and quality control solutions to support all stages of the drug development pipeline from discovery through preclinical and clinical development to commercial manufacture.
Our analytical capabilities and expertise covers the development of all medicines from traditional small molecule new chemical entities to therapeutic proteins, antibodies and other biopharmaceuticals, with experience in all major therapeutics areas and routes of administration. Our services range from the development, validation and application of bioanalytical methods for both small and large drug molecules and biomarkers, to full analytical and physical characterisation support for pharmaceutical product development.
- Discovery
- Pre clinical development
- Clinical development
- Life cycle management
From routine analysis to novel solutions for highly complex challenges, we have the scientific experience, technical capability and a proven track record of working in partnership with our customers. We will work with you to generate data, provide expert interpretation and answers, overcome hurdles to accelerate the development of your medicine, secure regulatory approval and/or enhance product competitiveness.
This is what makes us a leading outsourcing partner for numerous global pharmaceutical, biotechnology, healthcare and medical device companies.
In December 2012 LGC acquired the leading bioanalytical business from Quotient Bioresearch. All services offered by Quotient Bio Analytical Sciences now form part of the LGC Group. To read more on this story, please visit
LGC news
